The Future of Thiazolidinedione Therapy in the Management of Type 2 Diabetes Mellitus

Overview of attention for article published in Current Diabetes Reports, April 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

policy: 1 policy source
twitter: 1 X user

patent: 2 patents

Readers on

mendeley: 142 Mendeley

Summary Policy documents X Patents

So far, Altmetric has seen 2 patents that reference this research output.

5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3- thiazolidine-2,4-dione…

Grant US-11938122-B2

United States of America

5-[[4-[2-[5-(1-Hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione…

Application US-20200093812-A1

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.